Pro Share Advisors LLC Axogen, Inc. Transaction History

Pro Share Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$15.23 - $21.72 $150,700 - $214,919	-9,895 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$17.8 - $23.5 $1,406 - $1,856	-79 Reduced 0.79%	9,895 $214,000
Q1 2021 May 14, 2021	BUY	$17.18 - $22.6 $171,353 - $225,412	9,974 New	9,974 $202,000
Q3 2018 Nov 14, 2018	SELL	$34.05 - $55.9 $149,479 - $245,401	-4,390 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$36.15 - $52.5 $158,698 - $230,475	4,390 New	4,390 $221,000

176

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $749M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.